Literature DB >> 32976900

3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities.

Ogochukwu Lilian Okafor-Muo1, Hany Hassanin2, Reem Kayyali1, Amr ElShaer3.   

Abstract

Since the FDA approval of Spritam, there has been a growing interest in the application of 3D printing in pharmaceutical science. 3D printing is a method of manufacturing involving the layer-by-layer deposition of materials to create a final product according to a digital model. There are various techniques used to achieve this method of printing including the SLS, SLA, FDM, SSE and PB-inkjet printing. In biomanufacturing, bone and tissue engineering involving 3D printing to create scaffolds, while in pharmaceutics, 3D printing was applied in drug development, and the fabrication of drug delivery devices. This paper aims to review the use of some 3D printing techniques in the fabrication of oral solid dosage forms. FDM, SLA SLS, and PB-Inkjet printing processes were found suitable for the fabrication of oral solid dosage forms, though a great deal of the available research was focused on fused deposition modelling due to its availability and flexibility. Process parameters as well as strategies to control the characteristics of printed dosage forms are analysed and discussed. The review also presents the advantages and possible limitations of 3D printing of medicines.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  3D printing; Additive manufacturing; Oral solid dosage forms; Tablets

Mesh:

Substances:

Year:  2020        PMID: 32976900     DOI: 10.1016/j.xphs.2020.08.029

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Functionally graded additive manufacturing for orthopedic applications.

Authors:  Saquib Rouf; Abrar Malik; Ankush Raina; Mir Irfan Ul Haq; Nida Naveed; Ali Zolfagharian; Mahdi Bodaghi
Journal:  J Orthop       Date:  2022-07-03

2.  [Preparation and in vitro evaluation of fused deposition modeling 3D printed compound tablets of captopril and hydrochlorothiazide].

Authors:  Z S Li; H N Qian; T Y Fan
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-06-18

3.  3D printing of nanocomposite pills through desktop vat photopolymerization (stereolithography) for drug delivery reasons.

Authors:  Peeyush Kumar Sharma; Dinesh Choudhury; Vivek Yadav; U S N Murty; Subham Banerjee
Journal:  3D Print Med       Date:  2022-01-17

4.  Model optimization and performance evaluation of hand cranked music box base structure manufactured via 3D printing.

Authors:  Naufal Achmad Salman Alfarisi; Gil Nonato C Santos; Rachmadi Norcahyo; Jayan Sentanuhady; Nikmatul Azizah; Muhammad Akhsin Muflikhun
Journal:  Heliyon       Date:  2021-11-20

Review 5.  Application and Development of Modern 3D Printing Technology in the Field of Orthopedics.

Authors:  Binglong Li; Meng Zhang; Qunshan Lu; Baoqing Zhang; Zhuang Miao; Lei Li; Tong Zheng; Peilai Liu
Journal:  Biomed Res Int       Date:  2022-02-15       Impact factor: 3.411

Review 6.  Additive Manufacturing Strategies for Personalized Drug Delivery Systems and Medical Devices: Fused Filament Fabrication and Semi Solid Extrusion.

Authors:  Giulia Auriemma; Carmela Tommasino; Giovanni Falcone; Tiziana Esposito; Carla Sardo; Rita Patrizia Aquino
Journal:  Molecules       Date:  2022-04-27       Impact factor: 4.411

Review 7.  The Evolution of the 3D-Printed Drug Delivery Systems: A Review.

Authors:  Ildikó Bácskay; Zoltán Ujhelyi; Pálma Fehér; Petra Arany
Journal:  Pharmaceutics       Date:  2022-06-21       Impact factor: 6.525

8.  Clinical Application of Digital 3D Reconstruction and 3D Printing Technology in Endometrial Cancer (EC) Surgery.

Authors:  Fang Luo; Qin Yang
Journal:  Comput Math Methods Med       Date:  2022-09-14       Impact factor: 2.809

Review 9.  3DP Printing of Oral Solid Formulations: A Systematic Review.

Authors:  Chiara R M Brambilla; Ogochukwu Lilian Okafor-Muo; Hany Hassanin; Amr ElShaer
Journal:  Pharmaceutics       Date:  2021-03-09       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.